Paradigm Biopharmaceuticals Appoints Dr Daniel Furtner as Chief Medical Officer
Position
Chief Medical Officer
Company
Paradigm Biopharmaceuticals
Description
Paradigm Biopharmaceuticals has appointed Dr Daniel Furtner as its new Chief Medical Officer. He succeeds Dr Donna Skerrett, who will remain with the company as Senior Scientific Advisor.
Quick answer
Paradigm Biopharmaceuticals Appoints Dr Daniel Furtner as Chief Medical Officer (September 17, 2026). Paradigm Biopharmaceuticals is based in Melbourne, Victoria, Australia.
- Who is the new Chief Medical Officer at Paradigm Biopharmaceuticals?
- Paradigm Biopharmaceuticals named Daniel Furtner Chief Medical Officer, announced September 17, 2026.
- What did Paradigm Biopharmaceuticals announce on September 17, 2026?
- Paradigm Biopharmaceuticals has appointed Dr Daniel Furtner as its new Chief Medical Officer. He succeeds Dr Donna Skerrett, who will remain with the company as Senior Scientific Advisor.
- Where did Daniel Furtner work before joining Paradigm Biopharmaceuticals?
- Daniel Furtner joins from CSL.
- What does Paradigm Biopharmaceuticals do?
- Paradigm Biopharmaceuticals is a Melbourne-based biotechnology company focused on innovative treatments for patients with osteoarthritis.
- Where is Paradigm Biopharmaceuticals based?
- Paradigm Biopharmaceuticals is based in Melbourne, Victoria, Australia.
- Which similar companies made leadership changes around the same time?
- Cyllene Therapeutics (September 17, 2026), Oxford Brain Diagnostics (September 15, 2026), AdvanCell (September 15, 2026) and Serapha Bio (September 15, 2026) also announced leadership changes within 45 days of Paradigm Biopharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Cyllene Therapeutics Appoints Marc Grasso as Chief Financial Officer (September 17, 2026)
- Oxford Brain Diagnostics Appoints Jieun Choe as Chief Executive Officer (September 15, 2026)
- AdvanCell Appoints Sean Cassidy as Chief Financial Officer (September 15, 2026)
- Serapha Bio Appoints Kenneth T. Mills as Chief Executive Officer and Daphne Karydas as Chief Financial Officer (September 15, 2026)
- Vyome Appoints Jerry Leonard as Chief Financial Officer (September 14, 2026)
- Q32 Bio Appoints José Trevejo as Chief Medical Officer and Ellie Hershberger as Chief Development Officer (September 14, 2026)
Who to call at Paradigm Biopharmaceuticals, and when
A new leader at Paradigm Biopharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Paradigm Biopharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Paradigm Biopharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Paradigm Biopharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Paradigm Biopharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Paradigm Biopharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.